The strong downregulation of Thy-1 in B9T-OC can also be seen as a trait opposite to a malignant phenotype, as Thy-1 is often used as a biomarker of several tumors, including HCC and cancer stem cells [44,45]. This evidence concerns the gene THY1 and hepatocellular carcinoma.